Antimicrobial resistance (AMR) is a major burden on global health care, there are unmet needs for innovative solutions. At Peptomer Therapeutics we invent novel antimicrobial technology to address AMR. Our innovative monomer platforms enables the design and synthesis of antimicrobial Peptides, peptidomimetics and Oligomers to treat infections with Multidrug-Resistant (MDR) strains of bacteria and fungi.